- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04545593
Positive Minds Strong Bodies Implementation (PMSB-E)
January 30, 2024 updated by: Margarita Alegria, PhD, Massachusetts General Hospital
Building Community Capacity for Disability Prevention for Minority Elders - Renewal
This study aims to address treatment and service disparities and prevent disability among racial/ethnic and linguistic minority elders.
It tests the effectiveness and implementation readiness of the Positive Minds-Strong Bodies Enhanced intervention (PMSB-E), a combined mental and physical health intervention designed to be implemented in low-resource community settings.
This renewal grant project includes a streamlined intervention with new components designed to improve and maintain participant outcomes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The Positive Minds-Strong Bodies Enhanced intervention addresses the dual challenges of mental health and physical disability among minority elders.
The core Positive Minds intervention includes 10 sessions offered by Community Health Workers over a maximum of 6 months, designed to identify and correct negative distortions or cognitions, promote behavioral activation and encourage supportive relationships.
Strong Bodies is a 36-session physical intervention consisting of a series of exercises conducted while wearing a weighted vest in a group setting over 6 months; both interventions include a group maintenance component to maintain gains.
The investigators will evaluate the acceptability, effectiveness and twelve-month sustainability of the Enhanced Positive Minds-Strong Bodies intervention (E-PMSB) offered by Community Health Workers (CHWs) and Exercise Trainers in community-based organizations (CBOs) and community clinics.
The intervention is offered in English, Spanish, Mandarin or Cantonese.
Study Type
Interventional
Enrollment (Estimated)
450
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Margarita Alegria, Ph.D.
- Phone Number: (617) 724-4987
- Email: malegria@mgh.harvard.edu
Study Contact Backup
- Name: Sheri Markle, MIA
- Phone Number: 617-643-5042
- Email: smarkle@mgh.harvard.edu
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Recruiting
- Massachusetts General Hospital
-
Contact:
- Margarita Alegria, PhD
- Phone Number: 617-724-4987
- Email: malegria@mgh.harvard.edu
-
Contact:
- Sheri L Markle, MIA
- Phone Number: 617-643-5042
- Email: smarkle@mgh.harvard.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
60 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Latino, Asian, Black, or non-Latino White adults 60+ years of age
- With mild, moderate or severe depressive or anxiety symptoms.
- Participants receiving medications for mental health will have this recorded and used as a covariate.
- Community-dwelling participants who have some mobility limitations but are not home-bound.
Exclusion Criteria:
- Any specialty mental health care (therapy sessions with psychiatrist, psychologist or social worker) in the past 3 months or scheduled in the coming month.
- Evidence that patient lacks capacity to consent or is cognitively impaired
- Current suicidal risk (score of 4 or 5 on Paykel suicide questionnaire), whereby participant will be connected to an emergency services or specialty provider per the study emergency protocol.
- Physically instability, acute or exacerbation of a chronic disease, or a neuro-musculoskeletal impairment
- Severe substance abuse
- Self-reported psychosis or schizophrenia
- Inability to commit to 2 sessions per week
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Positive Minds Strong Bodies Enhanced
The Positive Minds Strong Bodies Enhanced intervention (PMSB-E) consists of 10 sessions focused on mental health (PM) and 36 sessions focused on physical health (SB), along with a group maintenance component.
|
The Positive Minds Strong Bodies Enhanced intervention (PMSB-E) was designed to provide a single, integrated program that could address the dual challenges of mental health and disability among minority elders.
PMSB-E seeks to improve mood symptoms, identify and correct negative distortions or cognitions, promote behavioral activation through engaging the participant in pleasant activities, and encourage developing supportive relationships.
All sessions are tailored to the participant's needs using a collaborative approach.
|
Active Comparator: Enhanced Usual Care
The Enhanced Usual Care condition includes written materials on depression and anxiety and 4 calls to participants over the course of 6 months to assess symptoms and safety.
|
Participants in this arm will receive a booklet about anxiety and depression in Spanish, English, or Mandarin/Cantonese.
Research staff will call the participant 4 times over the course of 6 months to administer mental health items, a suicide questionnaire, and a question about medication side effects to mimic the administration schedule in the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability
Time Frame: 6 months at end of treatment
|
>/= 70% of participants attending >/= 50% of their intervention sessions, reporting satisfaction with treatment.
|
6 months at end of treatment
|
Hopkins Symptom Checklist-25 (change)
Time Frame: Baseline and 3, 6, and 12 months after baseline
|
Widely used measure of depression and anxiety in clinical monitoring and outcome assessment.
|
Baseline and 3, 6, and 12 months after baseline
|
Short Physical Performance Battery (change)
Time Frame: Baseline and 3, 6, and 12 months after baseline
|
Assessment of standing balance, timed 4-m walk, and timed test of five chair-rise repetitions, to assess functional limitations.
A virtual option will be used while in person assessment is not possible due to COVID-19.
|
Baseline and 3, 6, and 12 months after baseline
|
Late-Life Function and Disability Instrument (LLFDI) - functional component (change)
Time Frame: Baseline and 3, 6, and 12 months after baseline
|
Self-report instrument designed to measure both functional capacity and components of disability.
|
Baseline and 3, 6, and 12 months after baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 11, 2021
Primary Completion (Estimated)
September 30, 2024
Study Completion (Estimated)
September 30, 2024
Study Registration Dates
First Submitted
September 4, 2020
First Submitted That Met QC Criteria
September 10, 2020
First Posted (Actual)
September 11, 2020
Study Record Updates
Last Update Posted (Estimated)
January 31, 2024
Last Update Submitted That Met QC Criteria
January 30, 2024
Last Verified
January 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019P001292
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Gerbera Therapeutics, Inc.Not yet recruitingPostpartum Depression | Depression, Postpartum | Postnatal Depression | Post-partum Depression | Post-Natal DepressionUnited States
-
Lawson Health Research InstituteTerminated
Clinical Trials on Positive Minds Strong Bodies Enhanced
-
Vanderbilt University Medical CenterCompleted
-
Massachusetts General HospitalUniversity of North Carolina, GreensboroCompletedMental HealthUnited States
-
Boston UniversityNational Institute of Nursing Research (NINR); Spaulding Rehabilitation HospitalCompleted
-
University of Nebraska LincolnUniversity of Houston; University of Colorado, Colorado SpringsCompleted
-
Michigan State UniversityHenry Ford Health System; Butler Hospital; Pacific Institute for Research and...RecruitingPostpartum DepressionUnited States
-
University of Colorado, DenverCompletedPain | Emotion Regulation | Meditation | Mindfulness | AffectUnited States
-
University of PittsburghNational Cancer Institute (NCI); National Institutes of Health (NIH)RecruitingQuality of Life | Self-ManagementUnited States
-
Butler HospitalNational Institute of Mental Health (NIMH)CompletedDepression | Depression, PostpartumUnited States
-
Medical University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)Recruiting
-
East Carolina UniversityMedical University of South Carolina; University of Florida; University of South...Enrolling by invitationDepression, Anxiety | Trauma, Psychological | Disruptive Behavior DisorderUnited States